SEC Filing Summary: Lloyds Banking Group Plc (13F-HR)
Business Context and Reporting Period
This filing is a Form 13F-HR submitted by Lloyds Banking Group Plc, an institutional investment manager based in London, United Kingdom. The report covers the calendar quarter ended September 30, 2018. The filing was signed by Andrew Kellett, Operations Manager, Group Secretariat, on October 26, 2018. The report includes holdings for one other included manager: Lloyds Bank International Limited.
Key Financial Metrics
As a Form 13F-HR, this document discloses equity holdings rather than the issuer's operational financial performance. Consequently, the filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity for Lloyds Banking Group Plc itself. The only financial metric disclosed is the aggregate value of the reported holdings:
- Total Value of Reported Holdings: $8,183,000 (8,183 in thousands).
- Total Number of Holdings Entries: 68.
Material Changes
The filing text does not provide comparative data for the prior period (June 30, 2018) or detail specific material changes in holdings volume or value. The document serves as a snapshot of holdings at the end of the reporting period.
Guidance, Outlook, and Risks
This filing type does not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding the business operations of Lloyds Banking Group Plc. It strictly lists securities held with voting authority or dispositive authority.
Key Facts for Investor Verification
- Verify the specific list of 68 equity positions held by Lloyds Banking Group Plc in the full schedule of the filing to understand their investment strategy.
- Note that the total reported value ($8.18 million) represents the value of the disclosed holdings, not the total assets or market capitalization of Lloyds Banking Group Plc.
- Confirm that Lloyds Bank International Limited is included as a related manager under this filing.
- Recognize that this document does not reflect the bank's own financial health, loan book performance, or regulatory capital ratios.